27 results
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
”), and applicable foreign regulatory authorities, including the European Medicines Agency and the UK Medicines & Healthcare products Regulatory Agency … healthcare programs, and the regulations promulgated pursuant to such statutes;
(c)HIPAA, as amended by the Health Information Technology for Economic
S-3
EX-1.2
gyojw3ngykoj4
9 Nov 22
Shelf registration
4:15pm
8-K
EX-99.2
wgi0 vn360ur2wc08h
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
DEF 14A
7m0qtq1ss4a 1wpt1
26 Apr 22
Definitive proxy
4:05pm
10-K
toytpqqk52c5
1 Mar 22
Annual report
4:07pm
10-Q
f8q6n0qqcby bq9ghtc
2 Dec 21
Quarterly report
4:15pm
424B4
2ck f7z9nrjif0lxikmd
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
EX-1.1
c38qtab2792koqcp7
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
jsl dwl16se1g6
18 Oct 21
IPO registration (amended)
6:04am